Le Lézard
Classified in: Science and technology
Subject: PER

Kearney Elects Bob Willen Managing Partner and Chairman


New Managing Partner is focused on continuing firm growth and delivering value for clients

CHICAGO, May 7, 2024 /PRNewswire/ -- Effective immediately, Bob Willen has been elected the tenth managing partner and chairman of Kearney, the global management consulting firm. Bob succeeds Alex Liu, who was first elected in 2018, and has concluded his second term.

Bob joined Kearney in 1995 and was elected partner in 2003. He has more than 25 years of consulting experience leading strategic and organizational transformations for large commercial and government clients globally. From 2015 until his election as managing partner, Bob led Kearney's Middle East and Africa region, in addition to previous positions leading global aerospace and defense, automotive, transportation, and infrastructure practices.

Asked his top priority as managing partner, Bob said: "Having lived and worked on three continents, I understand the challenges our clients are facing around the globe and have seen firsthand how Kearney can be the difference through our relentless focus on results and innovation. I am proud to be elected Kearney's managing partner to build on our positive momentum over the past five years and to continue delivering impact and value for our clients."

In the past five years, Kearney has enjoyed consistent double-digit annual growth, while building an ownership-minded firm fit for the next generation of leaders. Under the leadership of Alex Liu, the firm created greater client impact in strategic operations and large-scale transformation and made six acquisitions in strategic growth areas: Cervello, Prokura, OPTANO, TEAMS Design, Silicon Foundry, and MSE. During Alex's tenure, the firm also expanded its digital and analytics expertise, investing in its teams and capabilities for the next major technological shift.

Kearney has been the difference for clients for nearly 100 years, and Bob will continue to drive the firm's trajectory and growth agenda together with his global leadership team.

Earlier in his career, Bob was an aerospace engineer at General Dynamics Space Systems (now United Launch Alliance), before making the switch to consulting. A former NCAA All-American and national level soccer player, he earned an MBA from the University of Virginia Darden School of Business, a master's in aerospace engineering from The University of Texas at Austin, and a BA in physics from the University of Virginia.

About Kearney
Kearney is a leading global management consulting firm. For nearly 100 years, we have been a trusted advisor to C-suites, government bodies, and nonprofit organizations. Our people make us who we are. Driven to be the difference between a big idea and making it happen, we work alongside our clients to regenerate their businesses to create a future that works for everyone. Learn more at www.kearney.com.

Media contact:
Meir Kahtan
MKPR
[email protected]
+1 917-864-0800

Kearney contact:
Kathleen Ford
[email protected]

SOURCE Kearney


These press releases may also interest you

at 06:13
eWTP Arabia Capital Technology Fund I ("Techology Fund I"), managed by eWTP Arabia Capital ("eWTPA"), one of the leading private equity firms in the Middle East, was listed in the Preqin League Tables as the the fifth top-performing VC funds in the...

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

18 mai 2024
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

18 mai 2024
"Maximizing customer retention and expansion is more important than ever for B2B SaaS companies," said Steven Forth, CEO of Ibbaka. "Our...

18 mai 2024
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

18 mai 2024
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...



News published on and distributed by: